Medical/Pharmaceuticals

Tianyin's Dr. James Jiayuan Tong is Invited to Speak at the CFO China Summit 2011 on January 19, 2011 at the St. Regis Hotel, Beijing

BEIJING, Nov. 16, 2010 /PRNewswire-Asia-FirstCall/ -- Dr. James Jiayuan Tong, Chief Financial Officer, Chief Business & Development Officer and Director of Tianyin Pharmaceutical (NYSE Amex: TPI) is invited to present at CFO China Summit 2011 which will be held at the St. Regis Hotel at 21 Jianguome...

2010-11-16 21:00 1000

Jiangbo Pharmaceuticals Announces First Quarter Fiscal Year 2011 Results

LAIYANG, China, Nov. 16, 2010 /PRNewswire-Asia-FirstCall/ -- Jiangbo Pharmaceuticals, Inc. (Nasdaq: JGBO) ("Jiangbo" or the "Company"), a pharmaceutical company with its principal operations in the People's Republic of China, today announced financial results for its first quarter ended September 30...

2010-11-16 21:00 838

China Biologic Products Announces Record Third Quarter 2010 Results

- Q3 revenue grew 33.2% to $36.0 million - Non-GAAP adjusted net income grew 48.7% to $10.5 million TAI'AN, China, Nov. 16, 2010 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical compani...

2010-11-16 20:00 984

Tiens Biotech Group (USA) Reports Third Quarter and Nine-Month Results

NEW YORK, Nov. 16, 2010, PRNewswire-Asia/ -- Tiens Biotech Group (USA), Inc. (the "Company" or "Tiens", NYSE AMEX: TBV), www.tiens-bio.com( http://www.prnasia.com/www.tiens-bio.com ), today announced financial results for the third quarter and nine months ended September 30, 2010. Revenue for the t...

2010-11-16 05:15 1039

Nutrastar Announces Third Quarter 2010 Financial Results

Financial Highlights for the Three Months Ended September 30, 2010: -- Recorded revenues of $6.46 million, an 81.2% increase Year-Over-Year -- Gross profit of $5.28 million, an increase of $2.51 million or 90.6% Year-Over-Year -- Net income rises 100.4% Year-Over-Year to $4.07 million, represent...

2010-11-15 20:00 690

WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2010 Annual General Meeting

SHANGHAI, Nov. 12, 2010 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX) today announced shareholder resolutions adopted at its annual general meeting of shareholders held in Hong Kong on November 10, 2010. At the meeting, WuXi PharmaTech shareholders approved the re-election of incu...

2010-11-12 23:25 985

Winner Medical Announces Preliminary Fiscal Fourth Quarter 2010 Results

Provides Preliminary Fiscal 2011 Guidance -Fiscal Q4 revenues up 2.1% to $28.2 million; net income increased 5.7% to $3.1 million -FY 2010 revenue increased 16.9% to $115.0 million; net income increased 43.4% to $13.1 million -Preliminary FY2011 revenue guidance: $138-$150 million, up 20%-30% YOY...

2010-11-12 00:00 1008

Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for First Quarter Fiscal 2011

LAIYANG, China, Nov. 11, 2010 /PRNewswire-Asia-FirstCall/ -- Jiangbo Pharmaceuticals, Inc. (Nasdaq: JGBO( http://studio-5.financialcontent.com/prnews?Page=Quote&Ticker=JGBO )) (the "Company" or "Jiangbo"), a pharmaceutical company with its principal operations in China, today announced that the Comp...

2010-11-12 03:45 749

Huifeng Bio-Pharmaceutical to Attend 2010 Maxim Group Growth Conference

XI'AN, China, Nov. 11, 2010 /PRNewswire-Asia-FirstCall/ -- Huifeng Bio-Pharmaceutical Technology, Inc. (OTC Bulletin Board: HFGB) ("the Company"), specializing in developing and producing botanical extracts and other raw materials for pharmaceuticals and food additives, today announced that Huifeng ...

2010-11-11 20:30 950

Lotus Pharmaceuticals Announces Third Quarter 2010 Financial Results

-- 3Q Revenues up 27.5% YoY to $18.5M -- 3Q Net Income up 24.3% YoY to $6.7M; EPS $0.12 -- Company reaffirms previous guidance of $73.6M in revenues and $21.4M in net income BEIJING, Nov. 11, 2010 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the...

2010-11-11 20:30 862

China BCT Reports Strong Third Quarter 2010 Results

-- Third quarter 2010 revenue rose 55% year-over-year to $52.5 million -- Third quarter 2010 net income rose 35.5% year-over-year to $6.9 million, or $0.18 per diluted share LIUZHOU CITY, China, Nov. 10, 2010 /PRNewswire-Asia/ -- China BCT Pharmacy Group, Inc., (OTC Bulletin Board: CNBI), ("Ch...

2010-11-10 21:00 1006

Tianyin Reports Record First Quarter Fiscal Year 2011 Financial Results

CHENGDU, China, Nov. 10, 2010 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine, branded generics and other pharmaceuticals announced financial results...

2010-11-10 22:14 1070

China Medical Technologies Receives SFDA Approval for its First Self-Developed PCR-based EGFR Assay for Lung Cancer Targeted Drugs

BEIJING, Nov. 10, 2010 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that it has received approval for its real-time PCR-based Epidermal Growth Factor Receptor ("EGFR...

2010-11-10 20:00 911

Huifeng Bio-Pharmaceutical Technology Enters into a US$3.9 Million Financing and Construction Agreement with Xi'an Jucheng Investment & Consulting Co., Ltd.

XI'AN, China, Nov. 10, 2010 /PRNewswire-Asia-FirstCall/ -- Huifeng Bio-Pharmaceutical Technology, Inc. (OTC Bulletin Board: HFGB) ("the Company"), specializing in developing and producing botanical extracts and other raw materials for pharmaceuticals and food additives, today announced it entered in...

2010-11-10 20:30 1065

Lotus Pharmaceuticals Announces Conference Call to Discuss Third Quarter 2010 Financial Results

BEIJING, Nov. 10, 2010 /PRNewswire-Asia/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a fast-growing, profitable developer, manufacturer and seller of medicine and drugs in the People's Republic of China ("PRC"), announced today that it will hold a conference...

2010-11-10 21:30 916

Nutrastar Announces Participation in Upcoming Brean Murray, Carret & Co 2010 China Growth Conference in New York

HARBIN, China, Nov.11, 2010 /PRNewswire-Asia-FirstCall/ -- Nutrastar International Inc. (OTC Bulletin Board: NUIN; "Nutrastar" or the "Company"), a leading producer and supplier of premium branded Traditional Chinese Medicine ("TCM") consumer products, today announced that the Company will be partic...

2010-11-11 21:00 1008

Tianyin to Attend Brean Murray, Carret & Co. 2010 China Growth Conference on November 17 - 18, 2010

CHENGDU, China, Nov. 10, 2010 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and other pharmaceuticals will attend Brean Murr...

2010-11-10 13:00 827

American Oriental Bioengineering Introduces Kangfuling Suppository

- New Women's Health Drug under Jinji Brand - NEW YORK, Nov. 9, 2010 /PRNewswire-Asia-FirstCall/ -- American Oriental Bioengineering, Inc. (NYSE: AOB), (the "Company" or "AOB"), a pharmaceutical company dedicated to improving healthcare through the development, manufacture and commercialization o...

2010-11-10 15:53 877

WuXi PharmaTech Announces Third-Quarter 2010 Results

SHANGHAI, Nov. 10, 2010 / PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading research and development outsourcing company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the United States, today announced its financial resul...

2010-11-10 06:00 928

China Biologic Products Schedules Conference Call to Discuss Third Quarter 2010 Results

TAI'AN, Shandong, China, Nov. 9, 2010 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic," or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that it will host a conference call at 9:00 a.m. EST on Tuesday, November...

2010-11-09 22:14 926
1 ... 335336337338339340341 ... 344